OCUL
USDOcular Therapeutix Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$11.200
Máximo
$11.355
Mínimo
$10.400
Volumen
1.84M
Fundamentos de la Empresa
Capitalización de Mercado
2.3B
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
2.72M
Bolsa
NGM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Ocular Therapeutix™ Reports Third Quarter 2025 Financial Results and Business Highlights
Recent Investor Day highlighted how AXPAXLI™ is positioned to redefine retina based on potential superiority label, market expansion, and immediate adoptability Announced today that SOL-R achieved target
TD Cowen Maintains Buy on Ocular Therapeutix, Raises Price Target to $20
TD Cowen analyst Tara Bancroft maintains Ocular Therapeutix with a Buy and raises the price target from $14 to $20.
Ocular Therapeutix™ to Report Third Quarter 2025 Financial Results on November 4, 2025
BEDFORD, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular")), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it plans
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.